Kievmedpreparat JSC (UKEX:KMED) Stock Based Compensation: ₴0.00 Mil (TTM As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

UKEX:KMED Kievmedpreparat JSC UKEX:KMED
20 GF Score
Price ₴45.00
View Full Analysis

What is Kievmedpreparat JSC Stock Based Compensation?

Kievmedpreparat JSC UKEX:KMED 20 Stock Based Compensation is ₴0.00 Mil as of . 20. GuruFocus rates UKEX:KMED with a GF Score™ of 20/100.

Kievmedpreparat JSC's Stock Based Compensation for the six months ended in . 20 was ₴0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in . 20 was ₴0.00 Mil.

Kievmedpreparat JSC Stock Based Compensation Related Terms

Kievmedpreparat JSC Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Kievmedpreparat JSC's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kievmedpreparat JSC Stock Based Compensation Chart

Kievmedpreparat JSC Annual Data
Trend
Stock Based Compensation

Kievmedpreparat JSC Semi-Annual Data
Stock Based Compensation
UKEX:KMED
20GF Score
Kievmedpreparat JSC UKEX:KMED
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kievmedpreparat JSC Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Stock Based Compensation for the trailing twelve months (TTM) ended in . 20 was ₴0.00 Mil.

What does a Stock Based Compensation of ₴0.00 Mil mean?
Kievmedpreparat JSC (UKEX:KMED) has a Stock Based Compensation of ₴0.00 Mil as of . 20. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Kievmedpreparat JSC and its competitors.
Is Kievmedpreparat JSC's Stock Based Compensation too high?
Kievmedpreparat JSC's current Stock Based Compensation is ₴0.00 Mil. Overall, Kievmedpreparat JSC has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Kievmedpreparat JSC's Stock Based Compensation compare to ?
Kievmedpreparat JSC's Stock Based Compensation of ₴0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Drug Manufacturers company?
A good Stock Based Compensation depends on the Drug Manufacturers industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Kievmedpreparat JSC and its competitors. Kievmedpreparat JSC's current Stock Based Compensation is ₴0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kievmedpreparat JSC stock overvalued right now?
Kievmedpreparat JSC (UKEX:KMED) has a current Stock Based Compensation of ₴0.00 Mil. The current Stock Based Compensation is ₴0.00 Mil. Kievmedpreparat JSC's overall GF Score™ is 20/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Kievmedpreparat JSC (UKEX:KMED), the current Stock Based Compensation is ₴0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kievmedpreparat JSC Business Description

Comparable Companies
Address 139 Saksaganskovo Street, Kyiv, UKR, 01032
Kievmedpreparat JSC is a pharmaceutical company that manufactures and markets both Rx and OTC medicines to Ukrainian and CIS markets.
20GF Score

Get the complete analysis for UKEX:KMED

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₴45.00
Price